MESO
Price
$16.25
Change
+$0.39 (+2.46%)
Updated
Aug 15 closing price
Capitalization
2.1B
10 days until earnings call
PULM
Price
$4.71
Change
-$0.31 (-6.18%)
Updated
Aug 15 closing price
Capitalization
17.2M
81 days until earnings call
Interact to see
Advertisement

MESO vs PULM

Header iconMESO vs PULM Comparison
Open Charts MESO vs PULMBanner chart's image
Mesoblast
Price$16.25
Change+$0.39 (+2.46%)
Volume$226.25K
Capitalization2.1B
Pulmatrix
Price$4.71
Change-$0.31 (-6.18%)
Volume$14.02K
Capitalization17.2M
MESO vs PULM Comparison Chart in %
Loading...
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MESO vs. PULM commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MESO is a Hold and PULM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (MESO: $16.25 vs. PULM: $4.71)
Brand notoriety: MESO and PULM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MESO: 111% vs. PULM: 44%
Market capitalization -- MESO: $2.1B vs. PULM: $17.2M
MESO [@Biotechnology] is valued at $2.1B. PULM’s [@Biotechnology] market capitalization is $17.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MESO’s FA Score shows that 0 FA rating(s) are green whilePULM’s FA Score has 0 green FA rating(s).

  • MESO’s FA Score: 0 green, 5 red.
  • PULM’s FA Score: 0 green, 5 red.
According to our system of comparison, PULM is a better buy in the long-term than MESO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MESO’s TA Score shows that 5 TA indicator(s) are bullish while PULM’s TA Score has 3 bullish TA indicator(s).

  • MESO’s TA Score: 5 bullish, 5 bearish.
  • PULM’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both MESO and PULM are a good buy in the short-term.

Price Growth

MESO (@Biotechnology) experienced а +8.12% price change this week, while PULM (@Biotechnology) price change was -7.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

MESO is expected to report earnings on Aug 27, 2025.

PULM is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MESO($2.1B) has a higher market cap than PULM($17.2M). MESO YTD gains are higher at: -17.929 vs. PULM (-32.521). PULM has higher annual earnings (EBITDA): -9.58M vs. MESO (-77.78M). MESO has more cash in the bank: 37.7M vs. PULM (7.71M). PULM has less debt than MESO: PULM (0) vs MESO (126M). MESO has higher revenues than PULM: MESO (5.67M) vs PULM (1.92M).
MESOPULMMESO / PULM
Capitalization2.1B17.2M12,233%
EBITDA-77.78M-9.58M812%
Gain YTD-17.929-32.52155%
P/E RatioN/AN/A-
Revenue5.67M1.92M295%
Total Cash37.7M7.71M489%
Total Debt126M0-
FUNDAMENTALS RATINGS
MESO vs PULM: Fundamental Ratings
MESO
PULM
OUTLOOK RATING
1..100
2553
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
3761
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PULM's Valuation (41) in the Biotechnology industry is somewhat better than the same rating for MESO (88). This means that PULM’s stock grew somewhat faster than MESO’s over the last 12 months.

PULM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as MESO (100). This means that PULM’s stock grew similarly to MESO’s over the last 12 months.

MESO's SMR Rating (96) in the Biotechnology industry is in the same range as PULM (98). This means that MESO’s stock grew similarly to PULM’s over the last 12 months.

MESO's Price Growth Rating (37) in the Biotechnology industry is in the same range as PULM (61). This means that MESO’s stock grew similarly to PULM’s over the last 12 months.

MESO's P/E Growth Rating (97) in the Biotechnology industry is in the same range as PULM (100). This means that MESO’s stock grew similarly to PULM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MESOPULM
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
Momentum
ODDS (%)
Bullish Trend 4 days ago
77%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 19 days ago
70%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
77%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MESO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWPZX21.550.06
+0.28%
AB Sustainable International Thematic Z
MVGLX18.350.02
+0.11%
MFS Low Volatility Global Equity R3
UGEIX12.24-0.02
-0.16%
Victory Global Equity Income
VAFCX25.65-0.05
-0.19%
Invesco American Franchise C
NMSCX22.02-0.14
-0.63%
Columbia Small Cap Index Inst

MESO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MESO has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MESO jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MESO
1D Price
Change %
MESO100%
+2.46%
QTTB - MESO
51%
Loosely correlated
+4.79%
AVTX - MESO
32%
Poorly correlated
+0.78%
ZURA - MESO
30%
Poorly correlated
-3.49%
PRTA - MESO
28%
Poorly correlated
+2.36%
TRAW - MESO
28%
Poorly correlated
-6.79%
More

PULM and

Correlation & Price change

A.I.dvisor tells us that PULM and INM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PULM and INM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
-6.18%
INM - PULM
29%
Poorly correlated
-0.85%
CRIS - PULM
24%
Poorly correlated
+8.93%
CERO - PULM
23%
Poorly correlated
-1.36%
MESO - PULM
23%
Poorly correlated
+2.46%
MOLN - PULM
23%
Poorly correlated
-1.42%
More